Nanosurf CoreAFM released
8 November 2016 | By Nanosurf
Nanosurf has just released the CoreAFM, the compact research AFM that offers best value for money...
List view / Grid view
News
AFSEM™ offers a solution for conductive AFM in SEM with self-sensing cantilevers
8 November 2016 | By Nanosurf
GETec and Nanosurf now offer self-sensing conductive cantilevers for AFSEM™ that enable conductivity probing in the vacuum environment of the SEM...
Flex-FPM used to assess water contamination risk from oocyst stiffness
8 November 2016 | By Nanosurf
Oocysts from the waterborne protozoa Cryptosporidium are micrometer-sized organisms that can be highly infectious...
Mucosis’ needle-free nasal spray vaccine for RSV trial starts
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Mucosis has begun a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London...
FDA grants priority review for Novartis’ first-line treatment of HR+/HER2- advanced breast cancer
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The US Food and Drug Administration (FDA) accepted Novartis’ new drug application (NDA) for filing and granted priority review for LEE011 (ribociclib)...
NICE says head and neck cancer drug cetuximab is not cost-effective
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
NICE was reconsidering cetuximab as part of its programme to appraise drugs that are currently available on the Cancer Drugs Fund...
Post-meal hyperglycaemia has negative impact on diabetic quality of life
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
New data from a study related to post-meal or postprandial glucose control, show that poor PPG control has a negative impact on diabetics quality of life...
UK regulatory support for Vtesse’s Niemann-Pick drug for children
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The MHRA has granted a Promising Innovative Medicine designation for VTS-270, Vtesse’s investigational drug for children with Niemann-Pick Type C1 disease...
Mundipharma announces EU regulatory submission for Nyxoid
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Studies showed that Nyxoid is bioequivalent to injectable naloxone as a first line treatment for opioid overdose, with an intranasal 1.8 mg dose...
Up to 10-fold increase in assay sensitivity – discover Morffi™ at MEDICA 2016
3 November 2016 | By BBI Solutions
BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016...
Rainin TerraRacks enhance process security for CROs
3 November 2016 | By METTLER TOLEDO AG
Pelago Bioscience in Solna, Sweden, is taking advantage of the enhanced process security and convenience offered by METTLER TOLEDO’s Rainin TerraRack™ pipette tip racks...
UK Phase 2/3 acid sphingomyelinase deficiency trial begins
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Olipudase alfa is an enzyme replacement therapy being studied as a treatment of non-neurological manifestations of acid sphingomyelinase deficiency (ASMD)...
Verastem licenses Duvelisib from Infinity Pharmaceuticals for $28 million
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Verastem licensed exclusive worldwide rights to develop and commercialise Infinity's oncology product candidate duvelisib...
Wickham Labs to Exhibit at Pharmig 2016
3 November 2016 | By Wickham Laboratories Limited
Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th...
Life-extending breast cancer drug approved by NICE
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
NICE has said eribulin, which is also called Halaven and made by Eisai, should be an option for people with locally advanced or metastatic breast cancer...
